1. Network pharmacology analysis of Icariside II against bladder cancer
   Kancheng He et al, 2023, European Journal of Pharmacology CrossRef
2. Icariside II overcomes TRAIL resistance of melanoma cells through ROS-mediated downregulation of STAT3/cFLIP signaling
   Juan Du et al, 2016, Oncotarget CrossRef
3. Icariside II, a Broad-Spectrum Anti-cancer Agent, Reverses Beta-Amyloid-Induced Cognitive Impairment through Reducing Inflammation and Apoptosis in Rats
   Yuanyuan Deng et al, 2017, Frontiers in Pharmacology CrossRef
4. Icarisid II inhibits the proliferation of human osteosarcoma cells by inducing apoptosis and cell cycle arrest
   Yuanyuan Tang et al, 2017, Tumor Biology CrossRef
5. Effect of KNDC1 overexpression on the senescence of human umbilical vein endothelial cells
   Jinrui Ji et al, 2018, Molecular Medicine Reports CrossRef
6. Icariside II potentiates the anti-PD-1 antitumor effect by reducing chemotactic infiltration of myeloid-derived suppressor cells into the tumor microenvironment via ROS-mediated inactivation of the SRC/ERK/STAT3 signaling pathways
   Qing Kong et al, 2023, Phytomedicine CrossRef
7. The roles of glycolysis in osteosarcoma
   Zuxi Feng et al, 2022, Frontiers in Pharmacology CrossRef
8. Physalin A induces G2/M phase cell cycle arrest in human non-small cell lung cancer cells: involvement of the p38 MAPK/ROS pathway
   Ning Kang et al, 2016, Molecular and Cellular Biochemistry CrossRef
9. Synthesis, evaluation of anti-breast cancer activity in vitro of ICS II derivatives and summary of the structure-activity relationship
   Ling Zhang et al, 2023, Bioorganic & Medicinal Chemistry CrossRef
10. Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers
    Jian Hou et al, 2016, Drug Delivery CrossRef
11. Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives
    Hui-Li Tan et al, 2016, Frontiers in Pharmacology CrossRef
12. Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers
    Fei Xu et al, 2021, Frontiers in Pharmacology CrossRef
13. Resveratrol attenuates retinal ganglion cell loss in a mouse model of retinal ischemia reperfusion injury via multiple pathways
    Kaibao Ji et al, 2021, Experimental Eye Research CrossRef
14. The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II
    Meixia Chen et al, 2016, Nutrients CrossRef
15. Icariside II, a phosphodiesterase 5 inhibitor, attenuates cerebral ischaemia/reperfusion injury by inhibiting glycogen synthase kinase‐3β‐mediated activation of autophagy
    Jianmei Gao et al, 2020, British Journal of Pharmacology CrossRef
16. Icariside II, a PDE5 Inhibitor, Suppresses Oxygen-Glucose Deprivation/Reperfusion-Induced Primary Hippocampal Neuronal Death Through Activating the PKG/CREB/BDNF/TrkB Signaling Pathway
    Fan Xu et al, 2020, Frontiers in Pharmacology CrossRef
17. Icariin as a potential anticancer agent: a review of its biological effects on various cancers
    Fang-Yuan Liu et al, 2023, Frontiers in Pharmacology CrossRef
18. Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma
    Ya-Guang Peng et al, 2018, Pharmaceutical Biology CrossRef
19. Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells
    Chao Zhang et al, 2016, Oncotarget CrossRef
20. Protective Role of N-Acetylcysteine on Isoprenaline-Induced Myocardial Injury: Histological, Immunohistochemical and Morphometric Study
    Sherif Mohamed Zaki et al, 2018, Cardiovascular Toxicology CrossRef